Iron stores, response to α-interferon therapy, and effects of iron depletion in chronic hepatitis C

Liver

Volumn 16, Issue 4, 1996, Pages 248-254

  Piperno, Alberto ^a,c   Sampietro, Maurizio ^b   D'Alba, Roberta ^a   Roffi, Luigi ^a   Fargion, Silvia ^b   Parma, Stefania ^a   Nicoli, Carlo ^a   Corbetta, Noemi ^b   Pozzi, Massimo ^a   Arosio, Valeria ^c   Boari, G ^d   Fiorelli, Gemino ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c SAN GERARDO HOSPITAL   (Italy)

^d UNIVERSITÀ CATTOLICA DEL SACRO CUORE   (Italy)

Author keywords

Chronic hepatitis C; HCV genotype; Iron; Liver iron concentration; Phlebotomy therapy; Serum ferritin; Transferrin saturation; interferon

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA INTERFERON; ANTIVIRUS AGENT; GAMMA GLUTAMYLTRANSFERASE;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CHRONIC HEPATITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HEPATITIS C; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; IRON OVERLOAD; IRON STORAGE; LIVER LEVEL; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PHLEBOTOMY; PROGNOSIS; TREATMENT OUTCOME;

EID: 9544221635     PISSN: 01069543     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0676.1996.tb00737.x     Document Type: Article

References (27)

1. FELTON C, LUSTBADER ED, MERTEN C, BLUMBERG BS. Serum iron and response to hepatitis B virus. Proc Natl Acad Sci USA 1979: 76: 2438-2441.
2. LUSTBADER ED, HANN H-WL, BLUMBERG BS. Serum ferritin as a predictor of host response to hepatitis B virus infection. Science 1983: 220: 423-425.
3. DI BISCEGLIE AM, AXIOTIS CA, HOOFNAGLE JH, BACON BR. Measurements of iron status in patients with chronic hepatitis. Gastroenterology 1992: 102: 2108-2113.
4. ISOMURA T, YANO M, HAYASHI H, SAKAMOTO N. Excess iron in the liver of patients with chronic hepatitis C. J Clin Electron Microscopy 1992: 25: 231-237.
5. PIPERNO A, D'ALBA R, ROFFI L, FARGION S, MANCIA G, FIORELLI G. Relation between α-interferon therapy response and liver iron stores in chronic hepatitis. Hepatology 1993: 18: 250A.
6. VAN THEIL, D, FRIEDLANDER L, FAGIUOLI S, WRIGHT H, IRISH W, GAVALER J. Response to α-interferon therapy is influenced by the iron content of the liver. J Hepatol 1994: 20: 410-415.
7. OLYNYK J, REDDY R, DEBISCEGLIE A, et al. Hepatic iron concentration as a predictor of response to α-interferon therapy in chronic hepatitis C. Gastroenterology 1995: 108: 1104-1109.
8. PIPERNO A, FARGION S, D'ALBA R, et al. Liver damage in Italian patients with hereditary hemochromatosis is highly influenced by hepatitis B and C virus infection. J Hepatol 1992: 16: 364-8.
9. PIPERNO A, ROFFI L, POZZI M, et al. Can iron depletion therapy ameliorate hepatocellular injury in anti HCV positive chronic hepatitis? Gastroenterology 1992: 102: A868.
10. HAYASHI H, TAKIKAWA T, NISHIMURA N, YANO M, ISOMURA T, SAKAMOTO N. Improvement of serum aminotransferase levels after phlebotomy in patients with chronic active hepatitis C and excess hepatic iron. Am J Gastroenterol 1994: 89: 986-988.
11. ROFFI L, COLLOREDO MELS G, ANTONELLI G, et al. Breakthrough during recombinant alpha interferon therapy in patients with chronic hepatitis C virus infection: prevalence, etiology, management. Hepatology 1995: 21: 645-648.
12. SAMPIETRO M, SALVADORI S, CORBETTA N, BADALAMENTI S, GRAZIANI G, FIORELLI G. Single-tube reverse transcription and heminested polymerase chain reaction of hepatitis C virus RNA to detect viremia in serologically negative hemodialysis patients. Int J Clin Lab Res 1995: 25: 52-54.
13. MCOMISH F, CHAN S, DOW B, GILLON J, FRAME W, CRAWFORD R, YAP P, et al. Detection of three types of hepatitis C virus in blood donors: investigation of type-specific differences in serologic reactivity and rate of alanine aminotransferase abnormalities. Transfusion 1993: 33: 7-13.
14. SIMMONDS P, ALBERTI A, ALTER H, et al. A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology 1994: 19: 1321-1324.
15. SHINDO M, DL BISCEGLIE AM, CHEUNG L, et al. Decrease in serum hepatitis C viral RNA during alpha interferon therapy for chronic hepatitis C. Ann Intern Med 1991: 115: 700-706.
16. SCHEUER PJ, WILLIAMS R, MUIR AR. Hepatic pathology i n relatives of patients with hemochromatosis. J Pathol Bacteriol 1962: 84: 53-64.
17. BARRY M, SHERLOCK S. Measurement of liver-iron concentration in needle-biopsy specimens. Lancet 1971: 1: 100-103.
18. BASSETT ML, HALLIDAY JW, POWELL LW. Value of hepatic iron measurements in early hemochromatosis and determination of the critical level associated with fibrosis. Hepatology 1986: 6: 24-29.
19. NORUSIS M. SPPS Advanced Statistics 6.1 . Chicago, IL: SPSS Inc., 1994: 1-30.
20. DEUGNIER Y, BATTISTELLI D, JOUANOLLE H, et al. Hepatitis B virus infection markers in genetic hemochromatosis. A study of 272 patients. J Hepatol 1991: 13: 286-290.
21. PIPERNO A, D'ALBA R, FARGION S, et al. Liver iron concentration in chronic hepatitis: a study of 98 patients. Eur J Gastroenterol Hepatol 1995: 7: 1203-1208.
22. ENOMOTO N, SATO C, KUROSAKI M, MARUMO F. Hepatitis C virus after interferon treatment has the variation in the hypervariable region of envelope 2 gene. J Hepatol 1994: 20: 252-261.
23. OKADA SL, AKAHANE Y, SUZUKI H, OKAMOTO H, MISHIRO S. The degree of variability in the amino terminal region of the E2/NS1 protein of hepatitis C virus correlates with responsiveness to interferon theraphy in viremic patients. Hepatology 1992: 16: 619-624.
24. BUKH J, MILLER R, PORCELL R. Genetic heterogeneity of hepatitis C virus: quasispecies and genotypes. Serum Liver Dis 1995: 15: 41-63.
25. HIRAYAMA M, KOHGO Y, KONDO H, et al. Regulation of iron metabolism in HepG2 cells: a possible role for cytokines in the hepatic deposition of iron. Hepatology 1993: 18: 874-880.
26. ARTHUR MJP. Reactive oxygen intermediates and liver injury. J Hepatol 1988: 6: 125-131.
27. HALLIWELL B, GUTTERIDGE JMC. Lipid peroxidation, oxygen radicals, cell damage, and antioxidant therapy. Lancet 1984: 1: 1396-1397.